A common and unsightly skin cancer that can turn deadly has been undetectable for more than a year in a patient treated with a new targeted immune-therapy in a clinical trial at HonorHealth Research ...

There are nearly 40,000 U.S. cases of cutaneous squamous cell carcinoma each year that advance to stages that are difficult to treat and life-threatening The investigational drug is an engineered ...

May 18 (Reuters) - Shares of Regeneron fell 11.8% premarket on Monday after the company's experimental treatment missed the ...

'If I had been diagnosed five years prior, who knows if I would be here,' says Ashley Walton, who after eight draining years of treatment has finally heard the magic word: remission. Not Ashley Walton ...

Add Yahoo as a preferred source to see more of our stories on Google. Herpes is a common virus that is getting a rebrand from University of Southern California researchers who are using it to treat ...

In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the combination of the immunotherapy drug avelumab and targeted agent cetuximab had ...

ST. PAUL, Minn., April 15 (UPI) --New York University researchers say a simple, gene-based blood test has shown to be highly accurate in predicting whether some stage III melanoma patients are likely ...

Please provide your email address to receive an email when new articles are posted on . Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous ...

GRAND RAPIDS, Mich. (WOOD) — Skin cancer is the most common form of cancer worldwide, and an estimated 1 in 5 Americans develop it by age 70, the Skin Cancer Foundation says. Luckily, there are ...

DAYTON, Ohio (WDTN)—All month long during May, we’re celebrating Skin Cancer Awareness Month with Dayton’s iTASC! Dayton Skin Care and Cancer Center’s Dr. Marcus Elias joined Living Dayton showing ...

SCOTTSDALE, Ariz. — May 20, 2025 — A common and unsightly skin cancer that can turn deadly has been undetectable for more than a year in a patient treated with a new targeted immune-therapy in a ...